Cargando…
Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
Autores principales: | Roseweir, Antonia K., McMillan, Donald C., Edwards, Joanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189185/ https://www.ncbi.nlm.nih.gov/pubmed/30297771 http://dx.doi.org/10.1038/s41416-018-0275-7 |
Ejemplares similares
-
ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer
por: Roseweir, Antonia K., et al.
Publicado: (2018) -
Comment on “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
por: Uzunparmak, Burak, et al.
Publicado: (2018) -
Comment on: “Exploring the best treatment options for BRAF-mutant metastatic colon cancer”
por: Milano, Gérard, et al.
Publicado: (2020) -
The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer
por: van Wyk, Hester C., et al.
Publicado: (2019) -
Relationship between tumour PTEN/Akt/COX-2 expression, inflammatory response and survival in patients with colorectal cancer
por: Roseweir, Antonia K., et al.
Publicado: (2016)